Impact of quantitative CT texture analysis on the outcome of CT-guided bone biopsy

IF 3.4 2区 医学 Q2 Medicine
Silvio Wermelskirchen , Jakob Leonhardi , Anne-Kathrin Höhn , Georg Osterhoff , Nikolas Schopow , Silke Zimmermann , Sebastian Ebel , Gordian Prasse , Jeanette Henkelmann , Timm Denecke , Hans-Jonas Meyer
{"title":"Impact of quantitative CT texture analysis on the outcome of CT-guided bone biopsy","authors":"Silvio Wermelskirchen ,&nbsp;Jakob Leonhardi ,&nbsp;Anne-Kathrin Höhn ,&nbsp;Georg Osterhoff ,&nbsp;Nikolas Schopow ,&nbsp;Silke Zimmermann ,&nbsp;Sebastian Ebel ,&nbsp;Gordian Prasse ,&nbsp;Jeanette Henkelmann ,&nbsp;Timm Denecke ,&nbsp;Hans-Jonas Meyer","doi":"10.1016/j.jbo.2024.100616","DOIUrl":null,"url":null,"abstract":"<div><p>Texture analysis can provide new imaging-based biomarkers. Texture analysis derived from computed tomography (CT) might be able to better characterize patients undergoing CT-guided percutaneous bone biopsy. The present study evaluated this and correlated texture features with bioptic outcome in patients undergoing CT-guided bone biopsy. Overall, 123 patients (89 female patients, 72.4 %) were included into the present study. All patients underwent CT-guided percutaneous bone biopsy with an 11 Gauge coaxial needle. Clinical parameters and quantitative imaging features were investigated. Random forest classifier was used to predict a positive biopsy result. Overall, 69 patients had osteolytic metastasis (56.1 %) and 54 had osteoblastic metastasis (43.9 %). The overall positive biopsy rate was 72 %. The developed radiomics model demonstrated a prediction accuracy of a positive biopsy result with an AUC of 0.75 [95 %CI 0.65 – 0.85]. In a subgroup of breast cancer patients, the model achieved an AUC of 0.85 [95 %CI 0.73 – 0.96]. In the subgroup of non-breast cancer patients, the signature achieved an AUC of 0.80 [95 %CI 0.60 – 0.99]. Quantitative CT imaging findings comprised of conventional and texture features can aid to predict the bioptic result of CT-guided bone biopsies. The developed radiomics signature aids in clinical decision-making, and could identify patients at risk for a negative biopsy.</p></div>","PeriodicalId":48806,"journal":{"name":"Journal of Bone Oncology","volume":"47 ","pages":"Article 100616"},"PeriodicalIF":3.4000,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2212137424000964/pdfft?md5=293625d54b9f75bc47fd2bff42864547&pid=1-s2.0-S2212137424000964-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Bone Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212137424000964","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Texture analysis can provide new imaging-based biomarkers. Texture analysis derived from computed tomography (CT) might be able to better characterize patients undergoing CT-guided percutaneous bone biopsy. The present study evaluated this and correlated texture features with bioptic outcome in patients undergoing CT-guided bone biopsy. Overall, 123 patients (89 female patients, 72.4 %) were included into the present study. All patients underwent CT-guided percutaneous bone biopsy with an 11 Gauge coaxial needle. Clinical parameters and quantitative imaging features were investigated. Random forest classifier was used to predict a positive biopsy result. Overall, 69 patients had osteolytic metastasis (56.1 %) and 54 had osteoblastic metastasis (43.9 %). The overall positive biopsy rate was 72 %. The developed radiomics model demonstrated a prediction accuracy of a positive biopsy result with an AUC of 0.75 [95 %CI 0.65 – 0.85]. In a subgroup of breast cancer patients, the model achieved an AUC of 0.85 [95 %CI 0.73 – 0.96]. In the subgroup of non-breast cancer patients, the signature achieved an AUC of 0.80 [95 %CI 0.60 – 0.99]. Quantitative CT imaging findings comprised of conventional and texture features can aid to predict the bioptic result of CT-guided bone biopsies. The developed radiomics signature aids in clinical decision-making, and could identify patients at risk for a negative biopsy.

CT 纹理定量分析对 CT 引导下骨活检结果的影响
纹理分析可提供新的基于成像的生物标记。通过计算机断层扫描(CT)获得的纹理分析也许能更好地描述在 CT 引导下进行经皮骨活检的患者的特征。本研究对此进行了评估,并将 CT 引导下骨活检患者的纹理特征与活检结果相关联。本研究共纳入 123 名患者(89 名女性,占 72.4%)。所有患者都在 CT 引导下使用 11 号同轴针进行了经皮骨活检。对临床参数和定量成像特征进行了研究。随机森林分类器用于预测阳性活检结果。总的来说,69 例患者有溶骨性转移(56.1%),54 例有成骨性转移(43.9%)。活检阳性率为 72%。所开发的放射组学模型对阳性活检结果的预测准确率为 0.75 [95 %CI 0.65 - 0.85]。在乳腺癌患者分组中,该模型的 AUC 为 0.85 [95 %CI 0.73 - 0.96]。在非乳腺癌患者分组中,该特征的 AUC 为 0.80 [95 %CI 0.60 - 0.99]。由常规特征和纹理特征组成的定量 CT 成像结果有助于预测 CT 引导下骨活检的生物学结果。所开发的放射组学特征有助于临床决策,并能识别有阴性活检风险的患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.20
自引率
2.90%
发文量
50
审稿时长
34 days
期刊介绍: The Journal of Bone Oncology is a peer-reviewed international journal aimed at presenting basic, translational and clinical high-quality research related to bone and cancer. As the first journal dedicated to cancer induced bone diseases, JBO welcomes original research articles, review articles, editorials and opinion pieces. Case reports will only be considered in exceptional circumstances and only when accompanied by a comprehensive review of the subject. The areas covered by the journal include: Bone metastases (pathophysiology, epidemiology, diagnostics, clinical features, prevention, treatment) Preclinical models of metastasis Bone microenvironment in cancer (stem cell, bone cell and cancer interactions) Bone targeted therapy (pharmacology, therapeutic targets, drug development, clinical trials, side-effects, outcome research, health economics) Cancer treatment induced bone loss (epidemiology, pathophysiology, prevention and management) Bone imaging (clinical and animal, skeletal interventional radiology) Bone biomarkers (clinical and translational applications) Radiotherapy and radio-isotopes Skeletal complications Bone pain (mechanisms and management) Orthopaedic cancer surgery Primary bone tumours Clinical guidelines Multidisciplinary care Keywords: bisphosphonate, bone, breast cancer, cancer, CTIBL, denosumab, metastasis, myeloma, osteoblast, osteoclast, osteooncology, osteo-oncology, prostate cancer, skeleton, tumour.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信